Trial Profile
Pharmacokinetic Interaction Between the Antimalarial Combination Artemether/Lumefantrine and Combination Antiretroviral Therapy Including Lopinavir/Ritonavir in HIV-Infected Adults.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Artemether/lumefantrine (Primary) ; Lopinavir/ritonavir
- Indications HIV infections
- Focus Pharmacokinetics
- 25 Jun 2010 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 07 Apr 2009 New trial record